Poolbeg Pharma Ltd. (GB:POLB) has released an update.
Poolbeg Pharma plc, a biopharmaceutical company, has announced the release of their Annual Report and Accounts for 2023 and notice of their upcoming Annual General Meeting (AGM) set for 13 June 2024. The company is known for developing innovative medicines for diseases with high unmet medical needs, including a focus on rare and orphan diseases. Poolbeg continues to grow its pipeline of products with a development strategy that emphasizes cost-effectiveness and AI-led programmes to accelerate discovery and development.
For further insights into GB:POLB stock, check out TipRanks’ Stock Analysis page.
